BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29517899)

  • 1. Photochemical Control of Protein Arginine Deiminase (PAD) Activity.
    Mondal S; Parelkar SS; Nagar M; Thompson PR
    ACS Chem Biol; 2018 Apr; 13(4):1057-1065. PubMed ID: 29517899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
    Mondal S; Thompson PR
    Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
    Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
    Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
    Front Immunol; 2021; 12():716250. PubMed ID: 34737738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
    Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
    Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
    Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
    ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interplay of structure and intrinsic disorder in the functionality of peptidylarginine deiminases, a family of key autoimmunity-related enzymes.
    Alghamdi M; Al Ghamdi KA; Khan RH; Uversky VN; Redwan EM
    Cell Mol Life Sci; 2019 Dec; 76(23):4635-4662. PubMed ID: 31342121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Selective Inhibitor of Protein Arginine Deiminase 2.
    Muth A; Subramanian V; Beaumont E; Nagar M; Kerry P; McEwan P; Srinath H; Clancy K; Parelkar S; Thompson PR
    J Med Chem; 2017 Apr; 60(7):3198-3211. PubMed ID: 28328217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interleukin-6.
    Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Ishigami A; Sumida T
    Mod Rheumatol; 2019 Nov; 29(6):964-969. PubMed ID: 30285515
    [No Abstract]   [Full Text] [Related]  

  • 10. The Development of Benzimidazole-Based Clickable Probes for the Efficient Labeling of Cellular Protein Arginine Deiminases (PADs).
    Nemmara VV; Subramanian V; Muth A; Mondal S; Salinger AJ; Maurais AJ; Tilvawala R; Weerapana E; Thompson PR
    ACS Chem Biol; 2018 Mar; 13(3):712-722. PubMed ID: 29341591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH Stimulates Peptidylarginine Deiminase Catalyzed Histone Citrullination in Gonadotrope Cells.
    Khan SA; Edwards BS; Muth A; Thompson PR; Cherrington BD; Navratil AM
    Mol Endocrinol; 2016 Oct; 30(10):1081-1091. PubMed ID: 27603413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halogen Bonding Increases the Potency and Isozyme Selectivity of Protein Arginine Deiminase 1 Inhibitors.
    Mondal S; Gong X; Zhang X; Salinger AJ; Zheng L; Sen S; Weerapana E; Zhang X; Thompson PR
    Angew Chem Int Ed Engl; 2019 Sep; 58(36):12476-12480. PubMed ID: 31276611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fluopol-ABPP HTS assay to identify PAD inhibitors.
    Knuckley B; Jones JE; Bachovchin DA; Slack J; Causey CP; Brown SJ; Rosen H; Cravatt BF; Thompson PR
    Chem Commun (Camb); 2010 Oct; 46(38):7175-7. PubMed ID: 20740228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer.
    Witalison EE; Cui X; Causey CP; Thompson PR; Hofseth LJ
    Oncotarget; 2015 Nov; 6(34):36053-62. PubMed ID: 26440311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspective on Protein Arginine Deiminase Activity-Bicarbonate Is a pH-Independent Regulator of Citrullination.
    Zhou Y; Mittereder N; Sims GP
    Front Immunol; 2018; 9():34. PubMed ID: 29403504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.
    Chumanevich AA; Causey CP; Knuckley BA; Jones JE; Poudyal D; Chumanevich AP; Davis T; Matesic LE; Thompson PR; Hofseth LJ
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G929-38. PubMed ID: 21415415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a highly sensitive fluorescence probe for peptidyl arginine deiminase (PAD) activity.
    Kunieda K; Kawaguchi M; Ieda N; Nakagawa H
    Bioorg Med Chem Lett; 2019 Apr; 29(7):923-928. PubMed ID: 30773431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses.
    Kawalkowska J; Quirke AM; Ghari F; Davis S; Subramanian V; Thompson PR; Williams RO; Fischer R; La Thangue NB; Venables PJ
    Sci Rep; 2016 May; 6():26430. PubMed ID: 27210478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled Delivery of Pan-PAD-Inhibitor Cl-Amidine Using Poly(3-Hydroxybutyrate) Microspheres.
    Ahmed D; Puthussery H; Basnett P; Knowles JC; Lange S; Roy I
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884657
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.